Drugs / Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06678373 | Nov 2024 → Apr 2026 overdue | Japanese encephalitis | Liaoning Chengda Biotechnology CO., LTD | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liaoning Chengda Inactivated Japanese Encephalitis Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06678373 ↗ |
| Modality | Vaccine | “inactivated Japanese encephalitis vaccine” NCT06678373 ↗ |